This little-known stock can nearly double on growing disease monitoring business, Piper Sandler says

The firm expects the company has a competitive position in an industry with a total addressable market of "tens of billions" of dollars.

This little-known stock can nearly double on growing disease monitoring business, Piper Sandler says
The firm expects the company has a competitive position in an industry with a total addressable market of "tens of billions" of dollars.